Literature DB >> 1923521

Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.

Y L Hu1, R G Ramsay, C Kanei-Ishii, S Ishii, T J Gonda.   

Abstract

Carboxyl-truncated forms of the product of the c-myb proto-oncogene (Myb) are encoded by the v-myb oncogene, the rearranged c-myb genes of certain murine cell lines and a transforming recombinant c-myb retrovirus. We report here an examination of the abilities of a series of carboxyl deletions of Myb to transform hemopoietic cells. Increasing degrees of truncation resulted in increasing transforming capacity until the deletions removed the region responsible for transactivation by Myb. Because the effects of these deletions on transformation paralleled their previously described effects on the transactivating capacity of Myb but did not correlate with their ability to repress transcription, our results imply that removal of a domain which negatively regulates transactivation is responsible for oncogenic activation of carboxyl-truncated forms of Myb. Moreover, these data support the view that activated forms of myb transform by increasing and/or deregulating the expression of other genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923521

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy.

Authors:  J A Iñiguez-Lluhí; D Pearce
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation.

Authors:  Yutaka Morita; Chie Kanei-Ishii; Teruaki Nomura; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

3.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Recurrent MYB rearrangement in blastic plasmacytoid dendritic cell neoplasm.

Authors:  K Suzuki; Y Suzuki; A Hama; H Muramatsu; M Nakatochi; M Gunji; D Ichikawa; M Hamada; R Taniguchi; S Kataoka; N Murakami; D Kojima; Y Sekiya; E Nishikawa; N Kawashima; A Narita; N Nishio; Y Nakazawa; H Iwafuchi; K-I Watanabe; Y Takahashi; M Ito; S Kojima; S Kato; Y Okuno
Journal:  Leukemia       Date:  2017-03-27       Impact factor: 11.528

5.  Myb controls G(2)/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc.

Authors:  Masahiro Okada; Hiroshi Akimaru; De-Xing Hou; Tomomi Takahashi; Shunsuke Ishii
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

6.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

7.  Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.

Authors:  A E Cuddihy; L A Brents; N Aziz; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.

Authors:  J Bies; V Nazarov; L Wolff
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Differential transcriptional activation by v-myb and c-myb in animal cells and Saccharomyces cerevisiae.

Authors:  R H Chen; J S Lipsick
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Mechanism of c-myc regulation by c-Myb in different cell lineages.

Authors:  J P Cogswell; P C Cogswell; W M Kuehl; A M Cuddihy; T M Bender; U Engelke; K B Marcu; J P Ting
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.